Literature DB >> 24915227

Pediatric Clostridium difficile infection: 6-year active surveillance in a defined patient population.

Nicole Le Saux1, Denise Gravel, Michael R Mulvey, Judy Dennis, Abdool S Yasseen, Nicholas Barrowman, Jennifer Bowes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24915227     DOI： 10.1086/676875

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  5 in total

1.  Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.

Authors:  Daniel E Freedberg; Esi S Lamousé-Smith; Jenifer R Lightdale; Zhezhen Jin; Yu-Xiao Yang; Julian A Abrams
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

Review 2.  Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027.

Authors:  Larry K Kociolek; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

3.  In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile.

Authors:  Tarun Mathur; Tarani Kanta Barman; Manoj Kumar; Diksha Singh; Ram Kumar; Manoj Kumar Khera; Makiko Yamada; Shin-Ichi Inoue; Dilip Jatashankar Upadhyay; Nobuhisa Masuda
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 4.  Breakthroughs in the treatment and prevention of Clostridium difficile infection.

Authors:  Larry K Kociolek; Dale N Gerding
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-10       Impact factor: 46.802

5.  Global burden of Clostridium difficile infections: a systematic review and meta-analysis.

Authors:  Evelyn Balsells; Ting Shi; Callum Leese; Iona Lyell; John Burrows; Camilla Wiuff; Harry Campbell; Moe H Kyaw; Harish Nair
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.